Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kris A Partridge

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Tissue Engineering|March 11, 2004
Gene delivery in bone tissue engineering: progress and prospects using viral and nonviral strategiesKris A Partridge, Richard O C Oreffo
The Journal of Pharmacy and Pharmacology|March 3, 2007
Gene therapy used for tissue engineering applicationsMieke Heyde, Kris A Partridge, Richard O C Oreffo, et al.
Biotechnology and Bioengineering|April 4, 2007
Development of a slow non-viral DNA release system from PDLLA scaffolds fabricated using a supercritical CO2 techniqueMieke Heyde, Kris A Partridge, Steven M Howdle, et al.
Infection and Immunity|July 16, 2002
Interaction of Neisseria meningitidis with human meningeal cells induces the secretion of a distinct group of chemotactic, proinflammatory, and growth-factor cytokinesMyron Christodoulides, Benjamin L Makepeace, Kris A Partridge, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 4, 2003
Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/pleiotrophin: osteoconductive biomimetic scaffolds for tissue engineeringXuebin Yang, Rahul S Tare, Kris A Partridge, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Tissue Engineering|March 11, 2004
Gene delivery in bone tissue engineering: progress and prospects using viral and nonviral strategiesKris A Partridge, Richard O C Oreffo
The Journal of Pharmacy and Pharmacology|March 3, 2007
Gene therapy used for tissue engineering applicationsMieke Heyde, Kris A Partridge, Richard O C Oreffo, et al.
Biotechnology and Bioengineering|April 4, 2007
Development of a slow non-viral DNA release system from PDLLA scaffolds fabricated using a supercritical CO2 techniqueMieke Heyde, Kris A Partridge, Steven M Howdle, et al.
Infection and Immunity|July 16, 2002
Interaction of Neisseria meningitidis with human meningeal cells induces the secretion of a distinct group of chemotactic, proinflammatory, and growth-factor cytokinesMyron Christodoulides, Benjamin L Makepeace, Kris A Partridge, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 4, 2003
Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/pleiotrophin: osteoconductive biomimetic scaffolds for tissue engineeringXuebin Yang, Rahul S Tare, Kris A Partridge, et al.
Pageof 1